<?xml version="1.0" encoding="UTF-8"?><!-- generator="WordPress/2.7.1" -->
<rss version="0.92">
<channel>
	<title>VALDOXAN (Agomelatine) - Official site</title>
	<link>http://www.valdoxan.com</link>
	<description></description>
	<lastBuildDate>Tue, 09 Feb 2010 14:36:30 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	
	<item>
		<title>FURTHER EVIDENCE OF VALDOXAN® SUPERIOR ANTIDEPRESSANT EFFICACY  IN DEPRESSED PATIENTS</title>
		<description>

Istanbul, Turkey, 15th September 2009 – Further evidence of the superior antidepressant efficacy of Valdoxan®/Thymanax® (agomelatine) over conventional selective serotonin reuptake inhibitors (SSRIs) and serotonin noradrenalin reuptake inhibitor (SNRI) antidepressants was presented today at the Servier satellite symposium on the occasion of the 22nd European College of Neuropsychopharmacology (ECNP) Congress, ...</description>
		<link>http://www.valdoxan.com/index.php/2009/09/22/further-evidence-of-valdoxan%c2%ae-superior-antidepressant-efficacy-in-depressed-patients/</link>
			</item>
</channel>
</rss>
